HER2 amplification has been shown to positively enhance PI3K/AKT/mTOR signaling, which is in charge of regulating various aspects of tumor biology, for instance tumor cell proliferation, invasion, and differentiation.[109] However, the specific function of the HER2–AKT pathway in breast cancer remains to be elucidated. Here, ERBB2 is linked to breast carcinoma.